Proposed Information Collection Activity: Administration for Children and Families Program Instruction-Children's Justice Act (OMB #0970-0425), 70832-70833 [2022-25223]
Download as PDF
<![CDATA[
70832
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Persons with Respiratory Symptoms Experiencing
Homelessness.
Enrollment in Symptom Screening ..
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2022–25242 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors, Deputy
Director for Infectious Diseases (BSC,
DDID)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC) announces the
following meeting for the Board of
Scientific Counselors, Deputy Director
for Infectious Diseases (BSC, DDID).
This virtual meeting is open to the
public via Zoom, limited only by the
number of web conference lines
available (500 lines). Pre-registration is
required by accessing the link below in
the addresses section.
DATES: The meeting will be held on
December 7, 2022, from 9:00 a.m. to
5:15 p.m., EST, and December 8, 2022,
from 8:30 a.m. to 1:00 p.m., EST.
ADDRESSES: Zoom virtual meeting. Preregistration is required by accessing the
link at https://cdc.zoomgov.com/
webinar/register/WN_
PbAc34lET9uD2RN8lopzig. Instructions
to access the meeting will be provided
following registration.
FOR FURTHER INFORMATION CONTACT:
Laura Hughes-Baker, Ph.D., Designated
Federal Officer, CDC, 1600 Clifton Road
NE, Mailstop H24–12, Atlanta, Georgia
30329–4027; Telephone: (404) 639–
1402; Email: LHughesBaker@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The BSC, DDID provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the CDC
Deputy Director for Infectious Diseases;
SUMMARY:
lotter on DSK11XQN23PROD with NOTICES1
Number of
respondents
Type of respondents
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
and the Directors of the National Center
for Emerging and Zoonotic Infectious
Diseases, the National Center for HIV,
Viral Hepatitis, STD, and TB
Prevention, and the National Center for
Immunization and Respiratory Diseases,
CDC, concerning strategies, goals, and
priorities for the programs and research
within the national centers and
monitors the overall strategic direction
and focus of DDID and the national
centers.
Matters to be Considered: The agenda
will include updates and discussions on
recent outbreaks and affected
populations, as well as brief reports
from two of the Board’s workgroups: the
Food Safety Modernization Act
Surveillance Working Group and the
Acute Flaccid Myelitis Task Force.
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–25276 Filed 11–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity: Administration for Children
and Families Program Instruction—
Children’s Justice Act (OMB #0970–
0425)
Children’s Bureau,
Administration for Children and
Families, U.S. Department of Health and
Human Services.
ACTION: Request for Public Comments.
AGENCY:
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
1,000
Number of
responses
per
respondent
Average
burden per
respons
(in hours)
1
30/60
The Administration for
Children and Families (ACF) is
requesting a 3-year extension of the ACF
Program Instruction—Children’s Justice
Act (Office of Management and Budget
(OMB) #0970–0425, expiration 6/30/
2023). There are no changes proposed to
the Program Instruction.
DATES: Comments due within 60 days of
publication. In compliance with the
requirements of the Paperwork
Reduction Act of 1995, ACF is soliciting
public comment on the specific aspects
of the information collection described
above.
ADDRESSES: You can obtain copies of the
proposed collection of information and
submit comments by emailing
infocollection@acf.hhs.gov. Identify all
requests by the title of the information
collection.
SUPPLEMENTARY INFORMATION:
Description: The Program Instruction,
prepared in response to the enactment
of the Children’s Justice Act, Title II of
Public Law 111–320, Child Abuse
Prevention and Treatment Act
Reauthorization of 2010, provides
direction to the states and territories to
accomplish the purposes of assisting
states in developing, establishing, and
operating programs designed to
improve: (1) the assessment and
investigation of suspected child abuse
and neglect cases, including cases of
suspected child sexual abuse and
exploitation, in a manner that limits
additional trauma to the child and the
child’s family; (2) the assessment and
investigation of cases of suspected child
abuse-related fatalities and suspected
child neglect-related fatalities; (3) the
investigation and prosecution of cases of
child abuse and neglect, including child
sexual abuse and exploitation; and (4)
the assessment and investigation of
cases involving children with
disabilities or serious health-related
problems who are suspected victims of
child abuse or neglect. This Program
Instruction contains information
collection requirements that are found
in Public Law 111–320 at sections
107(b) and 107(d), and pursuant to
receiving a grant award. The
information being collected is required
by statute to be submitted pursuant to
receiving a grant award. The
SUMMARY:
E:\FR\FM\21NON1.SGM
21NON1
Federal Register / Vol. 87, No. 223 / Monday, November 21, 2022 / Notices
information submitted will be used by
the agency to ensure compliance with
the statute; to monitor, evaluate, and
measure grantee achievements in
addressing the investigation and
70833
prosecution of child abuse and neglect;
and to report to Congress.
Respondents: State governments.
ANNUAL BURDEN ESTIMATES
Instrument
Total number
of respondents
Annual
number of
responses per
respondent
Average burden hours per
response
Annual burden
hours
Application and Annual Report ........................................................................
52
1
60
3,120
Estimated Total Annual Burden Hours: 3,120.
Comments: The Department
specifically requests comments on (a)
whether the proposed collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) the quality, utility,
and clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Consideration will be given
to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 5106c Sec. 107
(b)4; and 42 U.S.C. 5106 Sec. 107 (B)5.
electronic or written comments on this
public meeting must be submitted by
December 19, 2022. See the
SUPPLEMENTARY INFORMATION section for
registration date and further
information.
Mary B. Jones,
ACF/OPRE Certifying Officer.
Electronic Submissions
[FR Doc. 2022–25223 Filed 11–18–22; 8:45 am]
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
BILLING CODE 4184–25–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0656]
Animal Drug User Fee Act; Public
Meeting; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public meeting;
request for comments.
ACTION:
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following public
meeting entitled ‘‘Animal Drug User Fee
Act.’’ The purpose of the public meeting
is to discuss the proposed
recommendations for the
reauthorization of the Animal Drug User
Fee Act (ADUFA V) for fiscal years 2024
through 2028.
DATES: The public meeting will be held
virtually on December 7, 2022, from 1
p.m. to 3 p.m. Eastern Time. Either
lotter on DSK11XQN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
21:25 Nov 18, 2022
Jkt 259001
The public meeting will be
hosted via a live virtual webcast.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
The https://www.regulations.gov
electronic filing system will accept
comments until 11:59 p.m. Eastern Time
at the end of December 19, 2022.
Comments received by mail/hand
delivery/courier (for written/paper
submissions) will be considered timely
if they are received on or before that
date.
ADDRESSES:
PO 00000
Frm 00064
Fmt 4703
Sfmt 4703
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand Delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2011–N–0656 for ‘‘Animal Drug User
Fee Act; Public Meeting; Request for
Comments.’’ Received comments, those
filed in a timely manner (see
ADDRESSES), will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday
through Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 87, Number 223 (Monday, November 21, 2022)]
[Notices]
[Pages 70832-70833]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-25223]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity: Administration for
Children and Families Program Instruction--Children's Justice Act (OMB
#0970-0425)
AGENCY: Children's Bureau, Administration for Children and Families,
U.S. Department of Health and Human Services.
ACTION: Request for Public Comments.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) is
requesting a 3-year extension of the ACF Program Instruction--
Children's Justice Act (Office of Management and Budget (OMB) #0970-
0425, expiration 6/30/2023). There are no changes proposed to the
Program Instruction.
DATES: Comments due within 60 days of publication. In compliance with
the requirements of the Paperwork Reduction Act of 1995, ACF is
soliciting public comment on the specific aspects of the information
collection described above.
ADDRESSES: You can obtain copies of the proposed collection of
information and submit comments by emailing [email protected].
Identify all requests by the title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: The Program Instruction, prepared in response to the
enactment of the Children's Justice Act, Title II of Public Law 111-
320, Child Abuse Prevention and Treatment Act Reauthorization of 2010,
provides direction to the states and territories to accomplish the
purposes of assisting states in developing, establishing, and operating
programs designed to improve: (1) the assessment and investigation of
suspected child abuse and neglect cases, including cases of suspected
child sexual abuse and exploitation, in a manner that limits additional
trauma to the child and the child's family; (2) the assessment and
investigation of cases of suspected child abuse-related fatalities and
suspected child neglect-related fatalities; (3) the investigation and
prosecution of cases of child abuse and neglect, including child sexual
abuse and exploitation; and (4) the assessment and investigation of
cases involving children with disabilities or serious health-related
problems who are suspected victims of child abuse or neglect. This
Program Instruction contains information collection requirements that
are found in Public Law 111-320 at sections 107(b) and 107(d), and
pursuant to receiving a grant award. The information being collected is
required by statute to be submitted pursuant to receiving a grant
award. The
[[Page 70833]]
information submitted will be used by the agency to ensure compliance
with the statute; to monitor, evaluate, and measure grantee
achievements in addressing the investigation and prosecution of child
abuse and neglect; and to report to Congress.
Respondents: State governments.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Annual number Average burden
Instrument Total number of of responses hours per Annual burden
respondents per respondent response hours
----------------------------------------------------------------------------------------------------------------
Application and Annual Report............... 52 1 60 3,120
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 3,120.
Comments: The Department specifically requests comments on (a)
whether the proposed collection of information is necessary for the
proper performance of the functions of the agency, including whether
the information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Authority: 42 U.S.C. 5106c Sec. 107 (b)4; and 42 U.S.C. 5106 Sec.
107 (B)5.
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2022-25223 Filed 11-18-22; 8:45 am]
BILLING CODE 4184-25-P
